Results 111 to 120 of about 207,835 (296)

Use of fibrin film as a carrier for drug delivery: A long-acting delivery system for pilocarpine into the eye.

, 1982
Shôzô Miyazaki, Kuniaki Ishii, Masahiko Takada   +2 more
openalex   +2 more sources

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Selective chemotherapy for cancers by using monoclonal antibody to colorectal cancers as a carrier antibody bound anti-tumor drugs.

, 1988
Toshio Takahashi
openalex   +2 more sources

Carboxy derivatives of isoflavones as affinity carriers for cytotoxic drug targeting in adrenocortical H295R carcinoma cells [PDF]

, 2003
Dalia Sömjen, Naftali Stern, Esther Knoll, O. Sharon, Batya Gayer, Tikva Kulik, Förtüne Kohen   +6 more
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Recent Advances in Kaolinite Nanoclay as Drug Carrier for Bioapplications: A Review. [PDF]

Adv Sci (Weinh), 2023
Wu Q, Liao J, Yang H.
europepmc   +1 more source

Genipin‐crosslinked gelatin microspheres as a drug carrier for intramuscular administration: In vitro and in vivo studies [PDF]

, 2003
Huang‐Chien Liang, Wen‐Hsiang Chang, Kuei-Jhong Lin, Hsing‐Wen Sung   +3 more
openalex   +1 more source

Endoglin mediates the tumor‐ and metastasis‐promoting traits of stromal myofibroblasts in human breast carcinomas

Molecular Oncology, EarlyView.
Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo, Yoshihiro Mezawa, Zixu Wang, Ahmet Acar, Yasuhiko Ito, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Yataro Daigo, Takuya Shirakihara, Akira Orimo   +11 more
wiley   +1 more source

The Disposition of Serum Proteins as Drug-Carriers in Mice Bearing Sarcoma 180.

, 1993
Tetsuro Tanaka, Yoshiharu Kaneo, S Shiramoto, Sadao Iguchi   +3 more
openalex   +2 more sources

In vitro and in vivo biologic evaluation of long‐circulating biodegradable drug carriers loaded with the pure antiestrogen RU 58668 [PDF]

, 2003
Thibault Ameller, Véronique Marsaud, Philippe Legrand, Ruxandra Gref, Jack‐Michel Renoir   +4 more
openalex   +1 more source